Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax - Poll - MDSpire

Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax

  • By

  • Fangli Chen

  • Yuanqin Wang

  • Zhen Fu

  • Li Chang

  • Xuewei Jiang

  • Zhizhi Zhang

  • Chongyang Li

  • Ligen Liu

  • Li Yang

  • June 5, 2026

  • 0 min

Share

Original Source(s)

Targeting WNK1 suppresses acute myeloid leukemia progression and enhances sensitivity to venetoclax

  • by Fangli Chen, Yuanqin Wang, Zhen Fu, Li Chang, Xuewei Jiang, Zhizhi Zhang, Chongyang Li, Ligen Liu, Li Yang

  • June 5, 2026

Related Content

Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer

Case Report: Clinical case of a giant plexiform neurofibroma of the liver in a patient with deletion of exon 1 of the NF1 gene

Identification, design, and in vivo proof of concept of a shared APC neoantigen delivered via a self-amplifying RNA containing virus-like nanoparticle for cancer vaccination